United States Molecular Diagnostic Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

1.       Report Overview

1.1.    Report Description

1.2.    Research Methods

1.3.    Research Approaches

2.       Executive Summary

3.       Market Overview

3.1.    Introduction

3.2.    Market Dynamics

3.2.1.Drivers

3.2.2.Restraints

3.2.3.Opportunities

3.2.4.Challenges

3.3.    PEST-Analysis

3.4.    Porter's Diamond Model for the United States Molecular Diagnostic Market

3.5.    IGR-Growth Matrix Analysis

3.6.    Competitive Landscape in the United States Molecular Diagnostic Market

4.       United States Molecular Diagnostic Market by Device

4.1.    Polymerase Chain Reaction (PCR)

4.2.    Isothermal Nucleic Acid Amplification Technology (INAAT)

4.3.    DNA Sequencing & Next-Generation Sequencing (NGS)

4.4.    DNA Microarray

4.5.    Others

5.       United States Molecular Diagnostic Market by Application

5.1.    Infectious Diseases

5.1.1. Hepatitis

5.1.2. HIV

5.1.3. CT/NG

5.1.4. Other

5.2.    Oncology

5.2.1. Breast Cancer

5.2.2. Lung Cancer

5.2.3. Prostate Cancer

5.2.4. Other

5.3.    Genetic Tests

5.4.    Other

6.       United States Molecular Diagnostic Market by End User

6.1.    Hospital & Academic Laboratories

6.2.    Reference Laboratories

6.3.    Other

7.       Company Profiles

7.1.    Company 1

7.2.    Company 2

7.3.    Company 3

7.4.    Company 4

7.5.    Company 5